Linaclotide

Type: Keyphrase
Name: Linaclotide
First reported Sep 03 2014 - Updated Sep 04 2014 - 1 reports

IRONWOOD PHARMACEUTICALS : to Present at Morgan Stanley Global Healthcare Conference

IronwoodPharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate updateat the Morgan Stanley Global Healthcare Conference on Wednesday,September 10, 2014 at 8:00 a.m. Eastern Time at the Grand Hyatt New York.A live webcast of Ironwood's presentation ... [Published 4 Traders - Sep 03 2014]
First reported Sep 02 2014 - Updated Sep 02 2014 - 1 reports

Ironwood Appoints Two New Senior Executives to Support Continued Growth as a Leader in Gastroenterology

– Chief Financial Officer and Senior Vice President of Finance andCorporate Strategy –– Senior Vice President of Corporate Communications –CAMBRIDGE, Mass.--( BUSINESS WIRE )-- IronwoodPharmaceuticals, Inc. (NASDAQ: IRWD) announced today the appoin ... [Published Business Wire - Sep 02 2014]
First reported Sep 02 2014 - Updated Sep 02 2014 - 1 reports

Revival of 5-HT3 antagonism as treatment of IBS-D?

Advanced searchWhile drug development for chronic constipation and IBS with constipation has moved ahead with the marketing of prucalopride and linaclotide in many countries, the development of agents for functional diarrhoea and IBS-D has been more troubled. ... [Published British Journal of the Gut - Sep 02 2014]
First reported Aug 28 2014 - Updated Aug 28 2014 - 1 reports

Advances in Management of Constipation-predominant IBS

Abdulmajeed, A., Rabab, M., Sliem, H. and Hebatallah, N. (2011) Pattern of irritable bowel syndrome and its impact on quality of life in primary health care center attendees, Suez governorate, Egypt. Pan Afr Med J 9: 5.Andresen, V., Camilleri, M., Busciglio, ... [Published General Medicine eJournal - Aug 28 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

The Newest IBS Medicines

Irritable bowel syndrome (IBS) is an often misunderstood and underdiagnosed condition that affects about 15.3 million people in the United States.No one remedy works for all patients, so there’s a great medical need to develop new therapies for IBS, Andrew ... [Published ThirdAge - Aug 21 2014]
First reported Aug 18 2014 - Updated Aug 18 2014 - 1 reports

July 2014 Boxed Warning For Linzess: Irritable Bowel Syndrome / Constipation Drug May Be Unsafe And Dangerous For Children

FDA Drug Alert Warns That Linzess Should Not Be Used In Children Under Age 6 And Neither Safety Nor Efficacy Established For Those Under 18 Years Old (Posted by Tom Lamb at DrugInjuryWatch.com ) Linzess (linaclotide) Was approved by the FDA ... [Published Drug Injury Watch - Aug 18 2014]
First reported Aug 16 2014 - Updated Aug 16 2014 - 1 reports

Treating IBS

An estimated 5-15% of the world's population has Irritable Bowel Syndrome (IBS), a condition that can cause symptoms such as abdominal pain, diarrhoea or constipation, cramping and bloating, and gas. It can affect people at any age but is especially common ... [Published Bangladesh Daily Star - Aug 16 2014]
First reported Aug 14 2014 - Updated Aug 14 2014 - 1 reports

IBS, Chronic Constipation: New Guidelines Issued

By WebMD Health NewsReviewed by Arefa Cassoobhoy, MD, MPHAug. 07, 2014 -- New guidelines offer some new approaches to treating (IBS) and chronic constipation (CC).It's been several years since the last treatment guideline updates for either of these conditions. ... [Published eMedicine Health - Aug 14 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

LINZESS (Linaclotide) Capsule, Gelatin Coated [Forest Laboratories, Inc.]

First reported May 01 2014 - Updated May 01 2014 - 3 reports

Ironwood and Forest to Present Linaclotide Data at Digestive Disease Week® 2014

CAMBRIDGE, Mass. & NEW YORK--(EON: Enhanced Online News)--Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) and Forest Laboratories, Inc. (NYSE:FRX) announced today they will present linaclotide-related data during Digestive Disease Week® 2014 in Chicago, ... [Published EON Science - May 01 2014]
First reported Apr 25 2014 - Updated Apr 25 2014 - 1 reports

The Right Treatment for Irritable Bowel Syndrome

Irritable Bowel Syndrome affects an estimated 3 to 20 percent of the population, according to the federal National Digestive Diseases Information Clearinghouse (NDDIC). According to the NDDIC, IBS is a collection of symptoms, not a condition. It’s been ... [Published ThirdAge - Apr 25 2014]
First reported Apr 10 2014 - Updated Apr 11 2014 - 3 reports

Ironwood and Forest Launch New Direct-to-Consumer Awareness Campaign For LINZESS®

CAMBRIDGE, Mass. & NEW YORK--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) and Forest Laboratories, Inc. (NYSE:FRX) announced today that they have commenced a new direct-to-consumer (DTC) patient awareness campaign for LINZESS® (linaclotide), ... [Published Business Wire Photo/Multimedia News - Apr 10 2014]

Quotes

"That doesn't mean they don't work, it's just that they have not had high-quality research performed," he says. "More recently, some of the more traditional laxatives ... have actually been subjected to high-quality research and have been shown to work. I think for constipation we have quite aa few alternatives."

More Content

All (27) | News (8) | Reports (0) | Blogs (19) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
IRONWOOD PHARMACEUTICALS : to Present at Morgan... [Published 4 Traders - Sep 03 2014]
Ironwood Appoints Two New Senior Executives to ... [Published Business Wire - Sep 02 2014]
Revival of 5-HT3 antagonism as treatment of IBS-D? [Published British Journal of the Gut - Sep 02 2014]
Advances in Management of Constipation-predomin... [Published General Medicine eJournal - Aug 28 2014]
The Newest IBS Medicines [Published ThirdAge - Aug 21 2014]
July 2014 Boxed Warning For Linzess: Irritable ... [Published Drug Injury Watch - Aug 18 2014]
Treating IBS [Published Bangladesh Daily Star - Aug 16 2014]
IBS, Chronic Constipation: New Guidelines Issued [Published eMedicine Health - Aug 14 2014]
LINZESS (Linaclotide) Capsule, Gelatin Coated [... [Published DailyMed Drug Label Updates for the last seven ... - Jul 24 2014]
Ironwood and Forest to Present Linaclotide Data... [Published EON Science - May 01 2014]
Ironwood and Forest to Present Linaclotide Data... [Published Business Wire Science: Science News - May 01 2014]
Ironwood and Forest to Present Linaclotide Data... [Published Business Wire Health News - May 01 2014]
The Right Treatment for Irritable Bowel Syndrome [Published ThirdAge - Apr 25 2014]
Ironwood and Forest Launch New Direct-to-Consum... [Published Business Wire Photo/Multimedia News - Apr 10 2014]
Ironwood and Forest Launch New Direct-to-Consum... [Published Business Wire Health News - Apr 10 2014]
Ironwood and Forest Launch New Direct-to-Consum... [Published Business Wire News with Multimedia - Apr 10 2014]
Ironwood Receives Notice of Allowance for Metho... [Published EON Environment - Feb 10 2014]
Ironwood Receives Notice of Allowance for Metho... [Published EON Transportation - Feb 10 2014]
Ironwood Receives Notice of Allowance for Metho... [Published EON Business - Feb 10 2014]
Ironwood Receives Notice of Allowance for Metho... [Published EON Consumer - Feb 10 2014]
Ironwood Receives Notice of Allowance for Metho... [Published EON Retail - Feb 10 2014]
Ironwood Receives Notice of Allowance for Metho... [Published EON Manufacturing - Feb 10 2014]
Ironwood Receives Notice of Allowance for Metho... [Published EON Energy - Feb 10 2014]
Ironwood Receives Notice of Allowance for Metho... [Published EON Communications - Feb 10 2014]
Ironwood Receives Notice of Allowance for Metho... [Published EON: Enhanced Online News - Feb 10 2014]
Ironwood Receives Notice of Allowance for Metho... [Published EON Science - Feb 10 2014]
Ironwood Receives Notice of Allowance for Metho... [Published Business Wire Health News - Feb 10 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
July 2014 Boxed Warning For Linzess: Irritable ... [Published Drug Injury Watch - Aug 18 2014]
FDA Drug Alert Warns That Linzess Should Not Be Used In Children Under Age 6 And Neither Safety Nor Efficacy Established For Those Under 18 Years Old (Posted by Tom Lamb at DrugInjuryWatch.com ) Linzess (linaclotide) Was approved by the FDA ...
LINZESS (Linaclotide) Capsule, Gelatin Coated [... [Published DailyMed Drug Label Updates for the last seven ... - Jul 24 2014]
Updated Date: Jul 17, 2014 EST ...
Ironwood and Forest to Present Linaclotide Data... [Published EON Science - May 01 2014]
CAMBRIDGE, Mass. & NEW YORK--(EON: Enhanced Online News)--Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) and Forest Laboratories, Inc. (NYSE:FRX) announced today they will present linaclotide-related data during Digestive Disease Week® 2014 in Chicago, ...
Ironwood and Forest to Present Linaclotide Data... [Published Business Wire Science: Science News - May 01 2014]
CAMBRIDGE, Mass. & NEW YORK--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) and Forest Laboratories, Inc. (NYSE:FRX) announced today they will present linaclotide-related data during Digestive Disease Week® 2014 in Chicago, May 3 through ...
Ironwood and Forest to Present Linaclotide Data... [Published Business Wire Health News - May 01 2014]
CAMBRIDGE, Mass. & NEW YORK--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) and Forest Laboratories, Inc. (NYSE:FRX) announced today they will present linaclotide-related data during Digestive Disease Week® 2014 in Chicago, May 3 through ...
1 2 3 4
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.